معرفی
Paul Goodyer, MD, is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and a Professor in the Department of Pediatrics at McGill University's Faculty of Medicine and Health Sciences. He works in the Division of Nephrology at the MUHC and is affiliated with the Child Health and Human Development Program at the RI-MUHC's Centre for Translational Biology.
- Senior Scientist, RI-MUHC (Glen site)
- Professor, Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University
- Division of Nephrology, MUHC
Dr. Goodyer's research focuses on the molecular mechanisms of orphan kidney diseases, particularly in translating genetic discoveries into novel therapies. His work includes studying gene dysfunction in congenital nephron deficiency, maternal vitamin A deficiency's role in renal hypoplasia, and cell-based therapies for cystinosis. He also investigates non-canonical Wnt signaling in polycystic kidney disease pathogenesis.
His recent publications emphasize X-linked hypophosphatemia management, nephronophthisis genetics, ciliopathies, and translational approaches to rare renal disorders. Key collaborations include international studies on maternal nutrition impacts and cell therapy development.
Dr. Goodyer maintains clinical links through the Renal-Genetics Clinic at the Montreal Children's Hospital, integrating research with patient care for genetic kidney conditions.
